Search research articles
Contact Us
Filters
Showing results (131-140 of 147) with videos related to
Page
of 15
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2022
Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasma
D C T Chan, W K J Lam, E P Hui, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2013
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
K C Allen Chan, Peiyong Jiang, Carol W M Chan, et al.
The New England Journal of Medicine
|
August 10, 2017
Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer
K C Allen Chan, John K S Woo, Ann King, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
February 21, 2020
[Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study]
C Liu, Z C Jiang, C X Shao, et al.
Cancer
|
May 7, 2015
Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma
Edwin P Hui, Brigette B Y Ma, K C Allen Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 2021
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer
Caroline Even, Hung-Ming Wang, Shau-Hsuan Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2018
Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials
Yu-Pei Chen, Ling-Long Tang, Qi Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2018
Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial
Anthony T C Chan, Edwin P Hui, Roger K C Ngan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2018
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette B Y Ma, Wan-Teck Lim, Boon-Cher Goh, et al.
NEJM Evidence
|
February 6, 2024
Plasma Epstein-Barr Virus DNA and Risk of Future Nasopharyngeal Cancer
K C Allen Chan, W K Jacky Lam, Ann King, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 147) with videos related to
Sort By:
Page
of 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2022
Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasma
D C T Chan, W K J Lam, E P Hui, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2013
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
K C Allen Chan, Peiyong Jiang, Carol W M Chan, et al.
The New England Journal of Medicine
|
August 10, 2017
Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer
K C Allen Chan, John K S Woo, Ann King, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
February 21, 2020
[Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study]
C Liu, Z C Jiang, C X Shao, et al.
Cancer
|
May 7, 2015
Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma
Edwin P Hui, Brigette B Y Ma, K C Allen Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 2021
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer
Caroline Even, Hung-Ming Wang, Shau-Hsuan Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2018
Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials
Yu-Pei Chen, Ling-Long Tang, Qi Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2018
Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial
Anthony T C Chan, Edwin P Hui, Roger K C Ngan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2018
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette B Y Ma, Wan-Teck Lim, Boon-Cher Goh, et al.
NEJM Evidence
|
February 6, 2024
Plasma Epstein-Barr Virus DNA and Risk of Future Nasopharyngeal Cancer
K C Allen Chan, W K Jacky Lam, Ann King, et al.
Page
of 15